Biotech Firm InnoCare Delays Hong Kong IPO Step on Virus Fears

(Bloomberg) -- The world’s top initial public offering market has seen the impact of the novel coronavirus outbreak as a Chinese biotech firm decided to postpone investor meetings for its Hong Kong...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.